This resolution expresses congressional support for designating September 2026 as "Sickle Cell Disease Awareness Month" to educate Americans about sickle cell disease and promote awareness of research, early detection, treatments, and preventative care. Sickle cell disease is an inherited blood disorder affecting approximately 100,000 people in the United States, with disproportionately high rates among Black and African American infants, and it can cause severe complications including strokes, organ damage, and significantly shortened life expectancy. The resolution highlights recent medical advances, including the Food and Drug Administration's approval of two gene therapies (Casgevy and Lyfgenia) that can cure the disease, as well as ongoing Medicaid support programs in 32 states to help patients access these treatments. The resolution encourages Americans to hold events and activities during September 2026 to raise public awareness about sickle cell disease, its symptoms, available treatments, and patient services. This is a symbolic resolution that does not authorize any funding or create binding requirements, but rather expresses the House's support for raising awareness of this serious health condition.